Arkolith/Insider Trading/CMPI/Form 4

venBio Global Strategic GP II, Ltd.

10% OwnerCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed May 4, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.8M
Net Open-Market Flow
-$2.8M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2022Sell(S)38K$10.37$389K2.5M
May 3, 2022Sell(S)79K$10.37$824K2.6M
May 2, 2022Sell(S)154K$10.38$1.6M2.7M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-009528) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML